AssayIndex
QSC cross-section

QSC by compound

QSC records split by compound, with the index-wide comparison for the same compound beside each one. 32 compounds, 495 records. Cells below n=3 print their raw values instead of a median.

32 compounds495 records
CompoundClassReportsQSC median %Index median %Δ (pp)SpecPass %
SemaglutideIncretin6799.2398.87+0.3697.0100
TB-500Tissue-repair5699.8099.47+0.3398.5100
RetatrutideIncretin5298.6098.41+0.1996.5100
TirzepatideIncretin4499.4098.44+0.9597.0100
BPC-157Tissue-repair3499.9199.15+0.7598.0100
CJC-1295 with DACGrowth-hormone2198.9098.79+0.1197.5100
GHRP-6Growth-hormone2099.9399.65+0.2899.0100
AOD-9604Metabolic1899.7799.25+0.5298.0100
IpamorelinGrowth-hormone1699.7599.48+0.2799.0100
CJC-1295 (no DAC)Growth-hormone1499.0898.61+0.4798.0100
PT-141 (Bremelanotide)Melanocortin-receptor1399.6199.31+0.3098.5100
MOTS-cMetabolic1399.9399.18+0.7598.0100
DesmopressinHypothalamic1299.6299.46+0.1698.5100
AfamelanotideMelanocortin-receptor1299.9399.28+0.6598.0100
SS-31 (Elamipretide)Metabolic1199.9399.42+0.5198.5100
LiraglutideIncretin1099.2599.02+0.2397.5100
SelankNeuroactive1099.9299.13+0.7899.0100
PramlintideIncretin1099.1398.84+0.2897.5100
Kisspeptin-10Melanocortin-receptor1099.6699.27+0.4098.5100
ExenatideIncretin7 n=798.9498.94+0.0098.0100
HexarelinGrowth-hormone7 n=799.7498.72+1.0299.0100
SurvodutideIncretin7 n=798.9798.69+0.2896.5100
DihexaNeuroactive6 n=699.3199.84-0.5398.5100
Melanotan IIMelanocortin-receptor6 n=699.7999.24+0.5598.5100
Enclomiphene citrateNon-peptide5 n=599.9199.23+0.6898.5100
PinealonShort4 n=499.9299.24+0.6899.0100
MK-677 (Ibutamoren mesylate)Non-peptide3 n=399.5099.37+0.1398.5100
EpitalonShort2 n=2n<398.6399.0100
L-Glutathione (reduced)Short2 n=2n<399.0098.5100
TriptorelinHypothalamic1 n=1n<398.4798.5100
ARA-290Tissue-repair1 n=1n<399.4598.0100
IGF-1 LR3Growth-hormone1 n=1n<397.7595.0100
97.197.698.198.699.199.6100.1SemaglutideSemaglutide: Q1 98.94, median 99.23, Q3 99.43, n=67outlier 97.41outlier 98.13n=67TB-500TB-500: Q1 99.55, median 99.80, Q3 99.93, n=56outlier 98.52outlier 98.54outlier 98.90n=56RetatrutideRetatrutide: Q1 98.22, median 98.60, Q3 98.85, n=52n=52TirzepatideTirzepatide: Q1 99.02, median 99.40, Q3 99.68, n=44n=44BPC-157BPC-157: Q1 99.36, median 99.91, Q3 99.93, n=34n=34CJC-1295 with DACCJC-1295 with DAC: Q1 98.79, median 98.90, Q3 99.07, n=21outlier 98.14outlier 98.22outlier 98.27n=21GHRP-6GHRP-6: Q1 99.93, median 99.93, Q3 99.93, n=20outlier 99.29outlier 99.40outlier 99.88outlier 99.88n=20AOD-9604AOD-9604: Q1 99.37, median 99.77, Q3 99.89, n=18n=18IpamorelinIpamorelin: Q1 99.48, median 99.75, Q3 99.93, n=16n=16CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 98.69, median 99.08, Q3 99.52, n=14n=14PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.44, median 99.61, Q3 99.84, n=13outlier 98.74n=13MOTS-cMOTS-c: Q1 99.65, median 99.93, Q3 99.93, n=13n=13DesmopressinDesmopressin: Q1 99.51, median 99.62, Q3 99.93, n=12n=12AfamelanotideAfamelanotide: Q1 99.82, median 99.93, Q3 99.93, n=12outlier 99.55outlier 99.65n=12 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.